Average Co-Inventor Count = 5.86
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ucb Pharma, S.a. (6 from 179 patents)
2. Ucb Biopharma Sprl (5 from 138 patents)
3. Celltech Therapeutics Limited (5 from 81 patents)
4. Sanofi (3 from 1,455 patents)
5. Ucbbiopharma Srl (3 from 109 patents)
6. Celltech R&d Limited (2 from 68 patents)
21 patents:
1. 11912721 - Fused pentacyclic imidazole derivatives
2. 10980814 - Fused pentacyclic imidazole derivatives as modulators of TNF activity
3. 10906919 - Fused pentacyclic imidazole derivatives
4. 10202405 - Fused pentacyclic imidazole derivatives
5. 9873703 - Imidazopyridazine derivatives as modulators of TNF activity
6. 9815797 - Fused bicyclic heteroaromatic derivatives as modulators of TNF activity
7. 9550737 - TNF -α modulating benzimidazoles
8. 9309243 - Imidazopyridine derivatives as modulators of TNF activity
9. 8604051 - Thieno-pyridine derivatives as MEK inhibitors
10. 8487101 - Thieno-pyridine derivatives as MEK inhibitors
11. 8394822 - Thieno-pyridine derivatives as MEK inhibitors
12. 8350037 - Thieno-pyridine derivatives as MEK inhibitors
13. 8283359 - Thieno-pyridine derivatives as MEK inhibitors
14. 7795256 - Thieno-pyridinone derivatives as kinase inhibitors
15. 6579983 - 5-cyano-2-aminopyrimidine derivatives